Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:30:38 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 12.60 CHF | +3.11% |
|
+0.16% | -47.17% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 271M 316M 254M 232M 437M 30.14B 439M 3B 1.17B 15.19B 1.18B 1.16B 50.27B | P/E 2026 * |
-9.59x | P/E 2027 * | 35.2x |
|---|---|---|---|---|---|
| Enterprise Value | 310M 361M 290M 265M 500M 34.44B 501M 3.43B 1.34B 17.36B 1.35B 1.32B 57.45B | EV / Sales 2026 * |
28.5x | EV / Sales 2027 * | 6.37x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Newron Pharmaceuticals S.p.A.
| 1 day | +3.11% | ||
| 1 week | +0.16% | ||
| Current month | +8.06% | ||
| 1 month | +5.35% | ||
| 3 months | -11.14% | ||
| 6 months | -32.26% | ||
| Current year | -47.17% |
| 1 week | 12.1 |  | 12.7 |
| 1 month | 11.48 | | 13.44 |
| Current year | 11.24 | | 31.85 |
| 1 year | 8.05 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/12/26 | Buy | Chief Executive Officer | 2,000 | 0.0096% | ||
| 8/11/26 | Buy | Chief Technology Officer | 582 | 0.0028% | ||
| 8/10/26 | Buy | Chief Technology Officer | 1,418 | 0.0068% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.11% | +0.16% | +41.89% | +135.07% | 316M | |
| +0.10% | +0.44% | +2.80% | +23.74% | 50.96B | |
| +2.34% | +4.12% | +479.52% | +583.35% | 46.18B | |
| -0.75% | +1.35% | +24.65% | +85.13% | 42.73B | |
| +0.83% | +2.88% | +39.52% | +18.77% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| -0.47% | +0.39% | +29.90% | +135.07% | 17.28B | |
| -0.47% | -2.06% | - | - | 16.43B | |
| +0.25% | +0.25% | +12.03% | +28.88% | 14.73B | |
| +2.13% | +3.46% | +85.21% | +51.70% | 14.09B | |
| Average | +0.54% | +0.63% | +81.08% | +123.69% | 27.92B | |
| Weighted average by Cap. | +0.33% | +1.15% | +104.35% | +144.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.63M 10.15M 9.3M 17.51M 1.21B 17.56M 120M 46.99M 608M 47.43M 46.4M 2.01B | 44.83M 52.23M 41.97M 38.43M 72.4M 4.99B 72.6M 497M 194M 2.51B 196M 192M 8.32B |
| Net income | -31.17M -36.32M -29.19M -26.73M -50.35M -3.47B -50.49M -346M -135M -1.75B -136M -133M -5.79B | 5.02M 5.85M 4.7M 4.31M 8.11M 559M 8.14M 55.69M 21.77M 282M 21.97M 21.5M 932M |
| Net Debt | 38.68M 45.07M 36.22M 33.16M 62.47M 4.3B 62.65M 429M 168M 2.17B 169M 166M 7.18B | 14.72M 17.14M 13.78M 12.62M 23.77M 1.64B 23.83M 163M 63.78M 825M 64.37M 62.98M 2.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | CHF 12.60 | +3.11% | 49,333 |
| 26-08-26 | CHF 12.22 | -2.08% | 26,028 |
| 26-08-25 | CHF 12.48 | +2.30% | 21,195 |
| 26-08-24 | CHF 12.20 | -2.71% | 35,206 |
| 26-08-21 | CHF 12.54 | -0.32% | 33,073 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
